Familial Pityriasis Rubra Pilaris (PRP) via the CARD14 Gene
Summary and Pricing 
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
11137 | CARD14 | 81479 | 81479,81479 | $990 | Order Options and Pricing |
Pricing Comments
Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information. If the Sanger option is selected, CNV detection may be ordered through Test #600.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
The Sanger Sequencing method for this test is NY State approved.
For Sanger Sequencing click here.Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics 
Clinical Features
Pityriasis rubra pilaris (PRP) is a papulosquamous disease characterized by keratotic follicular papules, and salmon-colored skin rash covered in fine scales. Major clinical features include widespread erythematous plaques, follicular plugging, and palmoplantar keratoderma. PRP occurs 1 in 5,000 individuals, and the majority of cases are simplex. Familial cases are rare (~6.5% of all affected PRP cases) and may show early age of onset, incomplete penetrance, and variable expression (Fuchs-Telem et al. 2012).
Genetics
Pathogenic variants in the CARD14 gene cause autosomal dominant pityriasis rubra pilaris. The CARD14 protein is an activator of nuclear factor kappa B signaling which plays a key role in immune responses and inflammatory reactions. To date, somewhat more than 10 unique pathogenic variants have been reported. Nearly 80% of reported variants are missense with three splicing and a small in-frame deletion also having been reported (Fuchs-Telem et al. 2012; Inoue et al. 2016). No large deletions or duplications have been reported (Human Gene Mutation Database).
Clinical Sensitivity - Sequencing with CNV PGxome
In one small study, three unique CARD14 causative variants were found in 4 unrelated families affected with familial pityriasis rubra pilaris who were diagnosed based on both clinical and skin biopsy findings (Fuchs-Telem et al. 2012).
No large deletions and duplications involving CARD14 have been reported (Human Gene Mutation Database).
Testing Strategy
This test provides full coverage of all coding exons of the CARD14 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
Candidates for this test are patients with symptoms consistent with autosomal dominant familial pityriasis rubra pilaris, and the family members of patients who have known CARD14 mutations.
Candidates for this test are patients with symptoms consistent with autosomal dominant familial pityriasis rubra pilaris, and the family members of patients who have known CARD14 mutations.
Gene
Official Gene Symbol | OMIM ID |
---|---|
CARD14 | 607211 |
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Disease
Name | Inheritance | OMIM ID |
---|---|---|
Pityriasis rubra pilaris | AD | 173200 |
Citations 
Ordering/Specimens 
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel

PGnome (Genome) Sequencing Panel

ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.